Production (Stage)
Satellos Bioscience Inc.
MSCL.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.14M | -4.36M | -6.63M | -4.41M | -5.13M |
| Total Depreciation and Amortization | 1.00K | 8.60K | 2.20K | 2.20K | 2.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 639.00K | -518.60K | 3.17M | 371.20K | -161.00K |
| Change in Net Operating Assets | -1.87M | -705.80K | 256.60K | -97.90K | -232.00K |
| Cash from Operations | -7.37M | -5.58M | -3.21M | -4.14M | -5.52M |
| Capital Expenditure | -- | 0.00 | 0.00 | -2.90K | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -8.30M | 12.98M | 1.72M | -1.37M |
| Cash from Investing | -- | -8.30M | 12.98M | 1.72M | -1.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.00K | 43.40M | 221.00K | 16.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 9.85M | -- | -- | -- |
| Cash from Financing | 2.00K | 38.04M | 162.00K | 11.70K | -- |
| Foreign Exchange rate Adjustments | 3.00K | 297.90K | 31.50K | 4.40K | -116.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.36M | 24.46M | 9.97M | -2.40M | -7.01M |